{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:57:16Z","timestamp":1790675836138,"version":"4.1.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,5,27]],"date-time":"2015-05-27T00:00:00Z","timestamp":1432684800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Imaging Biol"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s11307-015-0866-0","type":"journal-article","created":{"date-parts":[[2015,5,26]],"date-time":"2015-05-26T11:10:44Z","timestamp":1432638644000},"page":"575-584","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":317,"title":["Comparison of [18F]DCFPyL and [68Ga]Ga-PSMA-HBED-CC for PSMA-PET Imaging in Patients with Relapsed Prostate Cancer"],"prefix":"10.1007","volume":"17","author":[{"given":"Markus","family":"Dietlein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Kobe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Kuhnert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Stockter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Schom\u00e4cker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Dietlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris D.","family":"Zlatopolskiy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Krapf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Richarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Neubauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Drzezga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Neumaier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,5,27]]},"reference":[{"key":"866_CR1","first-page":"81","volume":"3","author":"DA Silver","year":"1997","unstructured":"Silver DA, Pellicer I, Fair WR et al (1997) Prostate-specific membrane antigen expression in normal and malignant human tissues. Clin Cancer Res 3:81\u201385","journal-title":"Clin Cancer Res"},{"key":"866_CR2","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s00259-012-2298-2","volume":"40","author":"A Afshar-Oromieh","year":"2013","unstructured":"Afshar-Oromieh A, Malcher A, Eder M et al (2013) PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions. Eur J Nucl Med Mol Imaging 40:486\u2013495","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"866_CR3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00259-013-2525-5","volume":"41","author":"A Afshar-Oromieh","year":"2014","unstructured":"Afshar-Oromieh A, Zechmann CM, Malcher A et al (2014) Comparison of PET imaging with a 68Ga-labelled PSMA ligand and 18F-choline-based PET\/CT for the diagnosis of recurrent prostate cancer. Eur J Nucl Med Mol Imaging 41(1):11\u201320","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"866_CR4","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s00259-013-2660-z","volume":"41","author":"A Afshar-Oromieh","year":"2014","unstructured":"Afshar-Oromieh A, Haberkorn U, Schlemmer HP et al (2014) Comparison of PET\/CT and PET\/MRI hybrid systems using a 68Ga-labelled PSMA ligand for the diagnosis of recurrent prostate cancer: initial experience. Eur J Nucl Med Mol Imaging 41(5):887\u2013897","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"866_CR5","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00259-014-2949-6","volume":"42","author":"A Afshar-Oromieh","year":"2015","unstructured":"Afshar-Oromieh A, Avtzi E, Giesel FL et al (2015) The diagnostic value of PET\/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer. Eur J Nucl Med Mol Imaging 42:197\u2013209","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"866_CR6","author":"C Kratochwil","year":"2015","unstructured":"Kratochwil C, Giesel FL, Eder M et al (2015) [177Lu]Lutetium-labelled PSMA ligand-induced remission in a patient with metastatic prostate cancer. Eur J Nucl Med Mol Imaging. doi: 10.1007\/s00259-014-2978-1","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"866_CR7","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1007\/s00259-014-2713-y","volume":"41","author":"CM Zechmann","year":"2014","unstructured":"Zechmann CM, Afshar-Oromieh A, Armor T et al (2014) Radiation dosimetry and first therapy results with a 124I\/131I-labeled small molecule (MIP-1095) targeting PSMA for prostate cancer therapy. Eur J Nucl Med Mol Imaging 41:1280\u20131292","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"866_CR8","first-page":"3192","volume":"59","author":"SS Chang","year":"1999","unstructured":"Chang SS, Reuter VE, Heston WDW et al (1999) Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature. Cancer Res 59:3192\u20133198","journal-title":"Cancer Res"},{"key":"866_CR9","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1016\/j.humpath.2009.06.003","volume":"40","author":"MC Haffner","year":"2009","unstructured":"Haffner MC, Kronberger IE, Ross JS et al (2009) Prostate-specific membrane antigen expression in the neovasculature of gastric and colorectal cancer. Human Pathol 40:1754\u20131761","journal-title":"Human Pathol"},{"issue":"24","key":"866_CR10","doi-asserted-by":"crossref","first-page":"7645","DOI":"10.1158\/1078-0432.CCR-11-1357","volume":"17","author":"Y Chen","year":"2011","unstructured":"Chen Y, Pullambhatla M, Foss CA et al (2011) 2-(2-{1-Carboxy-5-[(6-[18F] fluoro-pyridine-3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic acid, [18F]DCFPyl, a PSMA-based PET imaging agent for prostate cancer. Clin Cancer Res 17(24):7645\u20137653","journal-title":"Clin Cancer Res"},{"key":"866_CR11","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1021\/bc200279b","volume":"23","author":"M Eder","year":"2012","unstructured":"Eder M, Sch\u00e4fer M, Bauder-W\u00fcst U et al (2012) (68) Ga-complex lipophilicity and the targeting property of a urea-based PSMA inhibitor for PET imaging. Bioconjug Chem 23:688\u2013697","journal-title":"Bioconjug Chem"},{"key":"866_CR12","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/2191-219X-2-23","volume":"2","author":"M Sch\u00e4fer","year":"2012","unstructured":"Sch\u00e4fer M, Bauder-W\u00fcst U, Leotta K et al (2012) A dimerized urea-based inhibitor of the prostate-specific membrane antigen for 68Ga-PET imaging of prostate cancer. EJNMMI Res 2:23","journal-title":"EJNMMI Res"},{"key":"866_CR13","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3390\/ph7070779","volume":"7","author":"M Eder","year":"2014","unstructured":"Eder M, Neels O, M\u00fcller M et al (2014) Novel preclinical and radiopharmaceutical aspects of [68Ga]Ga-PSMA-HBED-CC: a new PET tracer for imaging of prostate cancer. Pharmaceuticals 7:779\u2013796","journal-title":"Pharmaceuticals"},{"key":"866_CR14","author":"Z Szabo","year":"2015","unstructured":"Szabo Z, Mena E, Rowe SP et al (2015) Initial evaluation of [18F]DCFPyL for prostate-specific membrane antigen (PSMA)-targeted PET imaging of prostate cancer. Mol Imaging Biol. doi: 10.1007\/s11307-015-0850-8","journal-title":"Mol Imaging Biol"},{"key":"866_CR15","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s00259-014-2915-3","volume":"42","author":"T Krohn","year":"2015","unstructured":"Krohn T, Verburg FA, Pufe T et al (2015) [68Ga]PSMA-HBED uptake mimicking lymph node metastasis in coeliac ganglia: an important pitfall in clinical practice. Eur J Nucl Med Mol Imaging 42:210\u2013214","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"866_CR16","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s12253-008-9104-2","volume":"15","author":"S Mannweiler","year":"2009","unstructured":"Mannweiler S, Amersdorfer P, Trajanoski S et al (2009) Heterogeneity of prostate-specific membrane antigen (PSMA) expression in prostate carcinoma with distant metastasis. Pathol Oncol Res 15:167\u2013172","journal-title":"Pathol Oncol Res"},{"key":"866_CR17","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1002\/(SICI)1097-0142(19980601)82:11<2256::AID-CNCR22>3.0.CO;2-S","volume":"82","author":"DG Bostwick","year":"1998","unstructured":"Bostwick DG, Pacelli A, Blute M et al (1998) Prostate specific membrane antigen expression in prostate intraepithelial neoplasia and adenocarcinoma: a study of 184 cases. Cancer 82:2256\u20132261","journal-title":"Cancer"},{"key":"866_CR18","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00259-010-1604-0","volume":"38","author":"P Castellucci","year":"2011","unstructured":"Castellucci P, Fuccio C, Rubello D et al (2011) Is there a role for 11C-choline PET\/CT in the early detection of metastatic disease in surgically treated prostate cancer patients with a mild PSA increase <1.5 ng\/ml? Eur J Nucl Med Mol Imaging 38:55\u201363","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"866_CR19","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00259-011-1970-2","volume":"39","author":"V Graute","year":"2012","unstructured":"Graute V, Jansen N, \u00dcbleis C et al (2012) Relationship between PSA kinetics and [18F]fluorocholine PET\/CT detection rates of recurrence in patients with prostate cancer after total prostatectomy. Eur J Nucl Med Mol Imaging 39:271\u2013281","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"866_CR20","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.eururo.2011.07.060","volume":"60","author":"P Rigatti","year":"2011","unstructured":"Rigatti P, Suardi N, Briganti A et al (2011) Pelvic\/retroperitoneal salvage lymph node dissection for patients treated with radical prostatectomy with biochemical recurrence and nodal recurrence detected by [11C] choline PET\/CT. Eur Urol 60:935\u2013943","journal-title":"Eur Urol"},{"key":"866_CR21","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.radonc.2011.05.005","volume":"99","author":"M Souvatzoglou","year":"2011","unstructured":"Souvatzoglou M, Krause BJ, P\u00fcrschel A et al (2011) Influence of 11C-choline PET\/CT on the treatment planning for salvage radiation therapy in patients with biochemical recurrence of prostate cancer. Radiother Oncol 99:193\u2013200","journal-title":"Radiother Oncol"},{"key":"866_CR22","first-page":"44","volume":"6","author":"F W\u00fcrschmidt","year":"2011","unstructured":"W\u00fcrschmidt F, Petersen C, Wahl A et al (2011) [18F]fluoroethylcholine-PET\/CT imaging for radiation treatment planning of recurrent and primary prostate cancer with dose escalation to PET\/CT-positive lymph nodes. Radiation. Oncology 6:44","journal-title":"Oncology"}],"container-title":["Molecular Imaging and Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-015-0866-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11307-015-0866-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-015-0866-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T19:15:22Z","timestamp":1553627722000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11307-015-0866-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,27]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["866"],"URL":"https:\/\/doi.org\/10.1007\/s11307-015-0866-0","relation":{},"ISSN":["1536-1632","1860-2002"],"issn-type":[{"value":"1536-1632","type":"print"},{"value":"1860-2002","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,27]]}}}